Remove 2005 Remove Inventor Remove Patent Application
article thumbnail

…And The Covaxin Patent Saga Continues: BBIL Changes the Patent Application Again

SpicyIP

The Story Till Now On one hand, COVID-19 cases are rising yet again to everyone’s surprise, and on the other, the surprises from the Covaxin patent application don’t seem to stop. BBIL then did a quick about-face on this application and issued a clarification on June 22 that they would be refiling with proper credits to ICMR.

article thumbnail

Journey Through “Julys” on SpicyIP (2005 – Present)

SpicyIP

Kurian’s trail of transparency, discussions about authors and copyright societies, updates on the international IP landscape, or the hustle and bustle of the domestic IP domain, including Statements of Patent (Non-)Working, the journey through Junes had its own jilts and joys.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cross-Border Inventing

Patently-O

The chart below highlights an important trend in patenting: increased joint-inventorship where the inventors reside in different countries. The top (blue-circle) series looks generally at cross-border joint-inventing while the lower (orange-square) series reports a subset where at least one of the inventors has a US residence.

article thumbnail

Jumbo Patents

Patently-O

In 1982, the USPTO began charging a surcharge for patent applications that included >3 independent claims and >20 total claims. The chart below shows the percent of patents that I call “jumbo patents”–those with >50 claims (orange) and >100 claims (dashed-blue). by Dennis Crouch.

Patent 124
article thumbnail

Challenges of Proving Inventorship: Corroboration of All Inventive Facts

Patently-O

The also case stands out as Itou was clearly the first inventor, but this evidence was not taken into account due both to arcane pre-AIA rules and due to the IPR process focusing only on the published patent documents. Under this regulation, a third party’s US or PCT patent application becomes prior art once published.

article thumbnail

Battle for gene editing: the US Appeals Court rules on CRISPR patents

Garrigues Blog

Under this system, which has traditionally been applied in the US, the first person to invent has “priority”, even if they were not the first to file the patent application in question. Since Rockefeller University’s patent was Pre-AIA, the Appeal Board applied the “interference process” and invalidated SNIPR’s patents.

Editing 52
article thumbnail

New referrals to the Enlarged Board on the EPO's joint applicants approach to priority (G 1/22 & G 2/22)

The IPKat

In T 1933/12 , the Board of Appeal found that Article 87 EPC does not prevent an applicant for a first application (P1) sharing their right to priority with a joint-applicant for a subsequent European patent application (P2). The PCT application claimed priority from the US provisional US 60/571444 (P1).

Inventor 126